Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Able to understand and sign the written informed consent~* Subjects should have either normal renal function or have stable renal disease~Exclusion Criteria:~* History of heart disease~* Unstable or clinically significant other disorders such as respiratory, hepatic, metabolic, psychiatric or gastrointestinal disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- A-Patients with mild renal impairment (Type: EXPERIMENTAL): None
- B-Healthy subjects matched to Group A (Type: EXPERIMENTAL): None
- C-Patients with moderate renal impairment (Type: EXPERIMENTAL): None
- D-Healthy subjects matched to Group C (Type: EXPERIMENTAL): None
- E-Patients with severe renal impairment (Type: EXPERIMENTAL): None
- F-Healthy subjects matched to Group E (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).